Skytrofa FastStart Program

Funded

About

The Skytrofa FastStart Program is designed to support patients who are prescribed the drug Skytrofa. This program offers a significant benefit by providing a 4-week supply of Skytrofa and the SKYTROFA® Auto-Injector to commercially insured patients experiencing treatment delays due to denied coverage. The program ensures a smooth transition for patients within the United States, Puerto Rico, Guam, and the Virgin Islands, allowing them to begin their prescribed therapy promptly.

Insurance requirements: Commercially insured

Enrollment Forms

Enrollment Form

Benefits

•1 maximum fills per year

Program Requirements

•Valid only for residents in the US and Puerto Rico

•Enrollment Required: Yes

•Coverage Required: No

•Needs Based: No

•Activation Required: No

Program Details

•The FastStart Program is available for commercially insured patients experiencing a delay in treatment due to denied coverage determination or appeals, who have an open activeinsurance authorization

•HCP should fax or email completed Statement of Medical Necessity Form to: (Fax) 8884360193 or (Email) info@ascendissupport.com

•Within 7 business days of FastStart Program approval, an initial 4week supply of medication and the SKYTROFA® AutoInjector will be shipped directly to patients

•For assistance or additional information, call 8444427236, Monday Friday, 8 AM to 8 PM ET

Enrollment Forms

Enrollment Form